BioChange

BioChange Overview

BioChange specializes in tissue regeneration technology and is the developer of CellFoam, an injectable scaffold that stimulates tissue repair and remodeling at the site of injection. Based on natural biomaterials designed for implantation using a minimally invasive procedure, the scaffold mimics the healthy extra-cellular matrix and triggers the body to repair itself.

Cumulative Funding Raised Over Time ($)

Latest News

Sep 16, 2022 · www.timesofisrael.com

Israeli foam to reverse receding gums soon set for human use, after success on dogs

Sep 13, 2022 · www.israel21c.org

growth-positive

Dental implant holds promise for gum repair, regeneration - ISRAEL21c

Israeli startup BioChange has developed a tissue regeneration technology, ReGum, that has been shown to be effective in healing gum disease in dogs. The product is now commercially available for veterinary use and is reportedly the only product of its kind. A formulation for humans is expected within a few years. The products success was reported in the journal Frontiers in Veterinary Science. The company is now selling products in the veterinary and research markets and is committed to beginning its first clinical study in aesthetic dermatology in 2023.

CustomersExpand

Funding

Team Members

5

Employees: 11-50

Web & Social Links

Locations

HaYetsira St 13, Yokne'am Illit, Israel

Photos & Videos

2 item(s)

BioChange Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info